CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Allscripts - MDRX CFD

18.93
0.16%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 18.9
Open* 19.03
1-Year Change* 0.63%
Day's Range* 18.81 - 18.81
52 wk Range 13.59-23.25
Average Volume (10 days) 1.70783
Average Volume (3 months) 28.4505
Market Cap 2003.82
P/E Ratio 19.4961
Shares Outstanding 109260000
Revenue 837.191
EPS 0.9407
Dividend (Yield %) N/A
Beta 0.95929
Next Earnings Date Feb 22, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 30, 2022 18.90 0.56 3.05% 18.34 18.94 18.25
Nov 29, 2022 18.36 0.40 2.23% 17.96 18.58 17.96
Nov 28, 2022 18.11 -0.06 -0.33% 18.17 18.43 18.06
Nov 25, 2022 18.52 0.15 0.82% 18.37 18.85 18.33
Nov 23, 2022 18.56 0.23 1.25% 18.33 18.61 17.90
Nov 22, 2022 18.32 0.14 0.77% 18.18 18.37 18.01
Nov 21, 2022 18.18 0.51 2.89% 17.67 18.43 17.67
Nov 18, 2022 18.08 -0.34 -1.85% 18.42 18.70 18.02
Nov 17, 2022 18.27 0.72 4.10% 17.55 18.28 17.55
Nov 16, 2022 18.10 0.07 0.39% 18.03 18.15 17.53
Nov 15, 2022 18.11 0.15 0.84% 17.96 18.36 17.85
Nov 14, 2022 17.94 0.17 0.96% 17.77 18.43 17.65
Nov 11, 2022 18.04 -0.38 -2.06% 18.42 18.67 17.99
Nov 10, 2022 18.41 1.00 5.74% 17.41 18.41 17.40
Nov 9, 2022 17.48 0.48 2.82% 17.00 17.71 16.88
Nov 8, 2022 16.85 1.28 8.22% 15.57 17.06 15.56
Nov 7, 2022 16.16 0.46 2.93% 15.70 16.41 15.70
Nov 4, 2022 15.64 1.66 11.87% 13.98 15.83 13.97
Nov 3, 2022 13.87 -0.16 -1.14% 14.03 14.09 13.78
Nov 2, 2022 14.23 -0.02 -0.14% 14.25 14.66 14.20

Allscripts Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 1386.07 1497.71 1617.84 1632.61 1502.7 1503.04
Revenue 1386.07 1497.71 1617.84 1632.61 1502.7 1503.04
Cost of Revenue, Total 784.77 864.909 996.45 1022.32 937.005 883.472
Gross Profit 601.299 632.799 621.391 610.287 565.695 619.565
Total Operating Expense 1318.36 1650.51 1629.45 1732.95 1635.16 1417.47
Selling/General/Admin. Expenses, Total 334.521 400.688 432.849 400.808 389.941 313.814
Research & Development 178.534 202.282 258.736 245.443 206.061 193.671
Depreciation / Amortization 15.884 17.345 26.558 27.188 25.604 23.109
Unusual Expense (Income) 4.65 165.29 -85.139 37.188 76.544 3.402
Operating Income 67.71 -152.806 -11.613 -100.34 -132.455 85.569
Interest Income (Expense), Net Non-Operating -36.979 -36.719 -50.655 -42.507 -16.91 -11.409
Other, Net 0.829 -0.512 0.069 -138.904 0.054 87.666
Net Income Before Taxes 31.56 -190.037 -62.199 -281.751 -149.311 161.826
Net Income After Taxes 31.251 -169.179 -43.216 -241.383 -132.619 133.975
Minority Interest -0.146 1.566 4.527 0.424 0 0
Net Income Before Extra. Items 31.105 -167.613 -38.689 -240.959 -132.619 133.975
Total Extraordinary Items -56.757 -28.846 402.429 58.781 833.026 0.463
Net Income -25.652 -196.459 363.74 -182.178 700.407 134.438
Income Available to Common Excl. Extra. Items 31.105 -167.613 -38.689 -240.959 -132.619 133.975
Income Available to Common Incl. Extra. Items -25.652 -196.459 363.74 -182.178 700.407 134.438
Diluted Net Income -25.652 -196.459 363.74 -182.178 700.407 134.438
Diluted Weighted Average Shares 186.188 180.83 176.038 166.306 159.281 138.658
Diluted EPS Excluding Extraordinary Items 0.16706 -0.92691 -0.21978 -1.44889 -0.83261 0.96623
Diluted Normalized EPS 0.19179 -0.33277 -0.53414 -1.30354 -0.52025 0.98654
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 133.652 742.066 369.272 391.699 142.672
Revenue 133.652 742.066 369.272 391.699 142.672
Cost of Revenue, Total 70.735 440.268 220.498 222.706 69.191
Gross Profit 62.917 301.798 148.774 168.993 73.481
Total Operating Expense 125.923 718.351 348.805 350.312 136.1
Selling/General/Admin. Expenses, Total 32.164 160.798 78.794 74.222 41.318
Research & Development 20.66 100.392 45.54 47.739 23.42
Depreciation / Amortization 2.364 11.649 5.817 5.643 2.171
Operating Income 7.729 23.715 20.467 41.387 6.572
Interest Income (Expense), Net Non-Operating -3.121 -6.156 -3.874 -1.379 -2.534
Other, Net 0.798 17.794 4.7 65.172 0.012
Net Income Before Taxes 5.406 35.353 21.293 105.18 4.05
Net Income After Taxes 4.3 30.498 16.194 87.283 18.471
Net Income Before Extra. Items 4.3 30.498 16.194 87.283 18.471
Total Extraordinary Items 4.757 0.485 -0.014 -0.008 4.386
Net Income 9.057 30.983 16.18 87.275 22.857
Income Available to Common Excl. Extra. Items 4.3 30.498 16.194 87.283 18.471
Income Available to Common Incl. Extra. Items 9.057 30.983 16.18 87.275 22.857
Diluted Net Income 9.057 30.983 16.18 87.275 22.857
Diluted Weighted Average Shares 140.191 136.717 131.352 128.389 138.685
Diluted EPS Excluding Extraordinary Items 0.03067 0.22307 0.12329 0.67983 0.13319
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.03067 0.25616 0.11261 0.67985 0.13319
Unusual Expense (Income) 5.244 -1.844 0.002
Minority Interest 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 604.333 857.11 858.965 841.262 1153.22 1554.5
Cash and Short Term Investments 96.61 119.47 174.243 129.668 531.104 132.517
Cash & Equivalents 96.61 119.47 174.243 129.668 531.104 132.517
Total Receivables, Net 405.172 492.56 531.715 555.733 479.493 235.051
Accounts Receivable - Trade, Net 405.172 492.56 531.715 555.733 454.072 235.051
Prepaid Expenses 101.53 105.319 142.193 147.99 136.264 60.511
Other Current Assets, Total 1.021 139.761 10.814 7.871 6.361 1126.42
Total Assets 3832.16 4230.15 3181.48 3205.74 2917.62 2425.23
Property/Plant/Equipment, Total - Net 148.81 135.417 121.913 186.359 168.763 28.143
Property/Plant/Equipment, Total - Gross 419.986 380.694 401.116 506.71 492.736
Accumulated Depreciation, Total -271.176 -245.277 -279.203 -320.351 -323.973
Goodwill, Net 1924.05 1292.75 1373.74 1362.02 974.729 506.607
Intangibles, Net 905.282 630.418 640.741 618.071 479.804 224.378
Long Term Investments 149.1 11.332 10.744
Other Long Term Assets, Total 100.582 1314.46 114.242 119.139 86.674 83.429
Total Current Liabilities 667.077 889.625 797.73 1210.69 934.777 597.988
Accounts Payable 126.144 85.749 73.166 104.014 35.905 5.281
Accrued Expenses 133.067 146.677 179.777 326.855 203.456 91.706
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 26.735 28.789 21.055 364.547 0
Other Current Liabilities, Total 381.131 628.41 523.732 415.274 695.416 501.001
Total Liabilities 2599.69 3109.27 1630.37 1920.55 1251.38 1017.09
Total Long Term Debt 1304.65 909.072 648.307 551.049 167.587 350.062
Long Term Debt 1294.77 906.725 647.539 551.004 167.587 350.062
Capital Lease Obligations 9.877 2.347 0.768 0.045
Deferred Income Tax 141.752 23.258 58.47 21.038 18.186 16.625
Minority Interest 428.42 470.725 29.314 0
Other Liabilities, Total 57.796 816.588 96.55 137.774 130.825 52.416
Total Equity 1232.47 1120.88 1551.11 1285.19 1666.24 1408.14
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 2.68 2.693 2.709 2.725 2.745 2.766
Additional Paid-In Capital 1789.96 1781.06 1881.49 1907.35 1902.78 1962.39
Retained Earnings (Accumulated Deficit) -187.351 -338.15 132.842 -49.336 633.118 767.556
Treasury Stock - Common -310.993 -322.735 -460.543 -571.157 -870.558 -1321.81
Unrealized Gain (Loss) -6.028 -2.676 -5.584 -4.392
Other Equity, Total -55.801 0.691 0.195 0 -1.838 -2.765
Total Liabilities & Shareholders’ Equity 3832.16 4230.15 3181.48 3205.74 2917.62 2425.23
Total Common Shares Outstanding 180.51 180.831 171.224 162.475 139.942 116.114
Note Receivable - Long Term 0 71.879 67.559 43.682 28.174
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 1135.44 840.989 804.961 1554.5 1540.68
Cash and Short Term Investments 513.4 229.254 214.179 132.517 82.782
Cash & Equivalents 513.4 229.254 214.179 132.517 82.782
Total Receivables, Net 491.434 458.638 464.168 235.051 225.659
Accounts Receivable - Trade, Net 466.013 458.638 464.168 235.051 225.659
Prepaid Expenses 128.493 150.968 124.473 60.511 56.191
Other Current Assets, Total 2.11 2.129 2.141 1126.42 1176.05
Total Assets 2871.39 2540.3 2484.31 2425.23 2430.25
Property/Plant/Equipment, Total - Net 157.556 134.129 123.964 28.143 26.075
Goodwill, Net 974.772 974.834 974.427 506.607 520.187
Intangibles, Net 462.643 444.106 425.129 224.378 236.619
Note Receivable - Long Term 45.845 49.849 51.119 28.174 19.198
Other Long Term Assets, Total 95.139 96.393 104.706 83.429 87.492
Total Current Liabilities 880.336 596.079 566.94 597.988 646.855
Accounts Payable 26.886 26.782 21.801 5.281 15.548
Accrued Expenses 200.223 202.627 205.547 91.706 85.828
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 653.227 366.67 339.592 501.001 545.479
Total Liabilities 1192.73 1146.83 1065.72 1017.09 1077.15
Total Long Term Debt 169.442 421.312 373.187 350.062 377.059
Long Term Debt 169.442 421.312 373.187 350.062 377.059
Deferred Income Tax 16.898 17.797 16.494 16.625 0
Other Liabilities, Total 126.058 111.638 109.098 52.416 53.235
Total Equity 1678.66 1393.47 1418.59 1408.14 1353.11
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2.751 2.766 2.766 2.766 2.776
Additional Paid-In Capital 1906.53 1903.54 1952.1 1962.39 1922.03
Retained Earnings (Accumulated Deficit) 642.175 664.101 680.281 767.556 802.89
Treasury Stock - Common -870.558 -1174.5 -1213.31 -1321.81 -1371.48
Other Equity, Total -2.244 -2.437 -3.242 -2.765 -3.102
Total Liabilities & Shareholders’ Equity 2871.39 2540.3 2484.31 2425.23 2430.25
Total Common Shares Outstanding 140.625 125.011 122.57 116.114 114.792
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 3.03 -154.175 407.807 -182.602 -132.619 133.975
Cash From Operating Activities 243.94 247.911 67.891 46.254 -106.715 -75.428
Cash From Operating Activities 136.328 157.328 192.346 207.106 192.269 176.137
Deferred Taxes -4.52 -10.228 4.144 -37.97 -3.275 -2.099
Non-Cash Items 90.583 197.24 -476.32 78.081 -10.842 -359.954
Cash Taxes Paid 5.466 6.675 10.108 42.972 76.595 330.473
Cash Interest Paid 14.989 21.183 28.888 19.604 24.616 4.993
Changes in Working Capital 18.519 57.746 -60.086 -18.361 -152.248 -23.487
Cash From Investing Activities -1154.01 -412.972 248.013 -161.056 1615.19 -12.175
Capital Expenditures -124.286 -157 -144.617 -130.436 -105.018 -78.56
Other Investing Cash Flow Items, Total -1029.72 -255.972 392.63 -30.62 1720.21 66.385
Cash From Financing Activities 865.271 198.585 -292.983 67.343 -1109.76 -258.866
Financing Cash Flow Items 891.968 23.515 128.123 -92.993 -10.402 -16.423
Issuance (Retirement) of Stock, Net -121.157 -10.509 -137.645 -111.46 -334.863 -417.443
Issuance (Retirement) of Debt, Net 94.46 185.579 -283.461 271.796 -764.494 175
Foreign Exchange Effects -0.532 0.86 -0.624 0.203 1.212 -0.476
Net Change in Cash -45.327 34.384 22.297 -47.256 399.926 -346.945
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 8.593 30.498 46.692 133.975 18.471
Cash From Operating Activities 4.575 -196.362 -140.472 -75.428 69.261
Cash From Operating Activities 44.026 88.713 132.989 176.137 14.101
Deferred Taxes -1.122 -0.1 -1.65 -2.099 -17.042
Non-Cash Items -35.886 -309.269 -305.842 -359.954 38.475
Changes in Working Capital -11.036 -6.204 -12.661 -23.487 15.256
Cash From Investing Activities -18.989 -34.545 -54.873 -12.175 -44.199
Capital Expenditures -20.521 -38.566 -60.033 -78.56 -9.945
Other Investing Cash Flow Items, Total 1.532 4.021 5.16 66.385 -34.254
Cash From Financing Activities -7.514 -75.24 -125.32 -258.866 -62.966
Financing Cash Flow Items -7.514 -16.287 -16.367 -16.423 -13.287
Issuance (Retirement) of Stock, Net 0 -308.953 -308.953 -417.443 -49.679
Issuance (Retirement) of Debt, Net 0 250 200 175 0
Foreign Exchange Effects -0.027 0.065 -0.48 -0.476 -0.011
Net Change in Cash -21.955 -306.082 -321.145 -346.945 -37.915

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Allscripts Company profile

About Allscripts Healthcare Solutions Inc

Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations. The Company’s segments include the Hospitals and Large Physician Practices and the Veradigm. The Hospitals and Large Physician Practices reportable segment offers integrated clinical and financial management solutions, which primarily include (electronic health record) EHR-related software, related installation, support and maintenance, outsourcing and private cloud hosting. The Veradigm reportable segment offers payer and life sciences solutions, which are mainly targeted at payers, life sciences companies and other key healthcare stakeholders. The Veradigm also offers software applications for patient engagement and the sale of EHR software to single-specialty and small and mid-sized physician practices, including related clinical, financial, administrative and operational solutions.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Allscripts Healthcare Solutions Inc revenues remained flat at $1.5B. Net income before extraordinary items totaled $134M vs. loss of $132.6M. Revenues reflect Data, Analytics and Care Coordination segment increase from $261.3M to $552.2M, Other international segment increase of 13% to $53.7M, Canada segment increase of 2% to $16M.

Equity composition

Common Stock $.01 Par, 03/11, 199M auth., 252,492,000 issd., less 61,308,000 shs. in Treas. @ $613K Insiders own 7.49%. IPO: 7/23/99, 7M shs @ $16 by Goldman, Sachs & Co. PO: 3/00, 2.4M shares (1,092,000 by the Co.) @ $73 by Goldman, Sachs. All Preferred stock converted into Common upon IPO. 8/10 Name chanhe from Allscripts-misys Healthcare Solutions

Industry: Medical Software & Technology Services

Suite 2024
222 Merchandise Mart Plaza
CHICAGO
ILLINOIS 60654
US

Income Statement

People also watch

XRP/USD

0.40 Price
-3.380% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00317

Oil - Crude

82.81 Price
+2.730% 1D Chg, %
Long position overnight fee -0.0094%
Short position overnight fee -0.0042%
Overnight fee time 22:00 (UTC)
Spread 0.03

US100

12,018.10 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0159%
Short position overnight fee 0.0057%
Overnight fee time 22:00 (UTC)
Spread 1.8

Natural Gas

6.88 Price
-0.920% 1D Chg, %
Long position overnight fee 0.0480%
Short position overnight fee -0.0742%
Overnight fee time 22:00 (UTC)
Spread 0.005

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading